Search

Your search keyword '"Haapasalo, Annakaisa"' showing total 532 results

Search Constraints

Start Over You searched for: Author "Haapasalo, Annakaisa" Remove constraint Author: "Haapasalo, Annakaisa"
532 results on '"Haapasalo, Annakaisa"'

Search Results

2. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

3. Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features

4. A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease

6. Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models

7. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

9. New insights into the genetic etiology of Alzheimer’s disease and related dementias

11. Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype

12. Frontotemporal dementia patient-derived iPSC neurons show cell pathological hallmarks and evidence for synaptic dysfunction and DNA damage

14. Incidence and Prevalence of Early-Onset Dementia in Finland.

16. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

19. Intranasal insulin activates Akt2 signaling pathway in the hippocampus of wild-type but not in APP/PS1 Alzheimer model mice

21. Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques

23. Organotypic Hippocampal Slice Cultures from Adult Tauopathy Mice and Theragnostic Evaluation of Nanomaterial Phospho-TAU Antibody-Conjugates

24. Serum Cathepsin S Levels Do Not Show Alterations in Different Clinical, Neuropathological, or Genetic Subtypes of Frontotemporal Dementia Patients nor in Comparison to Healthy Control Individuals

27. Protective Alzheimer’s disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models

28. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

30. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

32. Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons

33. Autophagy

34. Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons

35. S327 phosphorylation of the presynaptic protein SEPTIN5 increases in the early stages of neurofibrillary pathology and alters the functionality of SEPTIN5

36. C9orf72 hexanucleotide repeat expansion leads to altered neuronal and dendritic spine morphology and synaptic dysfunction

39. Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis

40. Threshold of heteroplasmic truncating MT-ATP6 mutation in reprogramming, Notch hyperactivation and motor neuron metabolism

41. A Novel Genetic Marker for the C9orf72 Repeat Expansion in the Finnish Population

43. GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance

45. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1

46. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

47. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

48. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

49. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

50. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

Catalog

Books, media, physical & digital resources